These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17961036)

  • 21. Meningioma: an update.
    Lusis E; Gutmann DH
    Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Light at the end of the tunnel: towards an effective drug therapy for surgery- and radiation-refractory meningioma.
    Marosi C
    Neuro Oncol; 2015 Jan; 17(1):7-8. PubMed ID: 25378633
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series.
    Chamberlain MC; Johnston SK
    J Neurooncol; 2011 Sep; 104(3):765-71. PubMed ID: 21318318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative Therapeutic Strategies in the Treatment of Meningioma.
    Caruso G; Elbabaa SK; Gonzalez-Lopez P; Barresi V; Passalacqua M; Caffo M
    Anticancer Res; 2015 Dec; 35(12):6391-400. PubMed ID: 26637848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in meningioma therapy.
    Norden AD; Drappatz J; Wen PY
    Curr Neurol Neurosci Rep; 2009 May; 9(3):231-40. PubMed ID: 19348712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.
    Weller M; Roth P; Sahm F; Burghardt I; Schuknecht B; Rushing EJ; Regli L; Lindemann JP; von Deimling A
    J Natl Cancer Inst; 2017 Mar; 109(3):1-4. PubMed ID: 28376212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracranial meningiomas: diagnosis and treatment.
    Chamberlain MC; Blumenthal DT
    Expert Rev Neurother; 2004 Jul; 4(4):641-8. PubMed ID: 15853583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro testing to a panel of potential chemotherapeutics and current concepts of chemotherapy in benign meningiomas.
    Balik V; Sulla I; Park HH; Sarissky M
    Surg Oncol; 2015 Sep; 24(3):292-9. PubMed ID: 26099192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    Zador Z; King AT; Geifman N
    PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Biomarkers of Meningioma: A Focused Review.
    Pawloski JA; Fadel HA; Huang YW; Lee IY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningioma genomics: a therapeutic challenge for clinicians.
    Moussalem C; Massaad E; Minassian GB; Ftouni L; Bsat S; Houshiemy MNE; Alomari S; Sarieddine R; Kobeissy F; Omeis I
    J Integr Neurosci; 2021 Jun; 20(2):463-469. PubMed ID: 34258948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Earlier and sustained response with incidental use of cardiovascular drugs among patients with low- to medium-grade meningiomas treated with radiosurgery (SRS) or stereotactic radiotherapy (SRT).
    Pintea B; Kinfe TM; Baumert BG; Boström J
    Radiother Oncol; 2014 Jun; 111(3):446-50. PubMed ID: 24998705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.
    Gupta V; Samuleson CG; Su S; Chen TC
    Neurosurg Focus; 2007; 23(4):E9. PubMed ID: 17961046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment: Medical therapy for recurrent or progressive meningiomas remains elusive.
    Iwamoto FM
    Neurology; 2015 Jan; 84(3):285. PubMed ID: 25527267
    [No Abstract]   [Full Text] [Related]  

  • 35. Metastatic rhabdoid meningioma with BRAF V600E mutation and good response to personalized therapy: case report and review of the literature.
    Mordechai O; Postovsky S; Vlodavsky E; Eran A; Constantini S; Dotan E; Cagnano E; Weyl-Ben-Arush M
    Pediatr Hematol Oncol; 2015 Apr; 32(3):207-11. PubMed ID: 25116269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics.
    Yoshikawa A; Nakada M; Ohtsuki S; Hayashi Y; Obuchi W; Sato Y; Ikeda C; Watanabe T; Kawahara Y; Hasegawa T; Sabit H; Kita D; Hayashi Y; Nakanuma Y; Terasaki T; Hamada JI
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):105-10. PubMed ID: 21696419
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment for rare brain tumors veers from traditional tack.
    McBride G
    J Natl Cancer Inst; 1997 Jul; 89(13):912-3. PubMed ID: 9214668
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of Pharmacotherapy in Treatment of Meningiomas].
    Tamura R
    No Shinkei Geka; 2024 Jul; 52(4):825-838. PubMed ID: 39034520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical therapies for meningiomas.
    Wen PY; Quant E; Drappatz J; Beroukhim R; Norden AD
    J Neurooncol; 2010 Sep; 99(3):365-78. PubMed ID: 20820875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.